Induction of decay accelerating factor and membrane cofactor protein by resveratrol attenuates complement deposition

Maria G Detsika1, Eleni D Myrtsi2, Sofia D Koulocheri2

  • 1First Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Research Center of Intensive Care and Emergency Thoracic Medicine, Evangelismos Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Insights

Resveratrol, found in red wine, protects against cardiovascular disease by boosting heme-oxygenase (HO)-1. This increases complement regulatory proteins, reducing harmful C3b deposition in blood vessels.

Area of Science:

  • Cardiovascular Disease Research
  • Immunology and Complement System
  • Molecular Biology and Cell Signaling

Background:

  • Complement activation is implicated in cardiovascular disease (CVD) progression and treatment.
  • Resveratrol, a compound in red wine, shows protective effects against CVD, but its mechanisms are unclear.
  • Understanding resveratrol's molecular targets is crucial for developing targeted CVD therapies.

Purpose of the Study:

  • To investigate if resveratrol's CVD protective effects are mediated by upregulating complement regulatory proteins via heme-oxygenase (HO)-1 induction.
  • To assess resveratrol's impact on HO-1, membrane cofactor protein (MCP, CD46), decay-accelerating factor (DAF, CD55), and CD59 expression in human coronary artery endothelial cells (HCAECs).
  • To determine the role of HO-1 and DAF in resveratrol's ability to reduce complement-mediated C3b deposition.

Main Methods:

  • HCAECs were treated with resveratrol at concentrations found in red wine.
  • HO-1, MCP (CD46), DAF (CD55), and CD59 expression levels were measured.
  • HO-1 was silenced using siRNAs, and DAF function was blocked with an antibody.
  • C3b deposition was quantified after complement activation using normal human or rat serum.

Main Results:

  • Resveratrol significantly increased HO-1, MCP (CD46), and DAF (CD55) expression in HCAECs, with no effect on CD59.
  • Silencing HO-1 abolished resveratrol-induced MCP and DAF expression.
  • Resveratrol-induced MCP and DAF reduced C3b deposition.
  • Blocking DAF or silencing HO-1 increased C3b deposition in the presence of complement.

Conclusions:

  • Resveratrol protects against cardiovascular disease through a novel mechanism involving HO-1 induction.
  • HO-1 upregulates complement regulatory proteins DAF and MCP, which reduce harmful C3b deposition.
  • This study highlights the critical role of the HO-1/DAF pathway in mediating resveratrol's cardioprotective effects.

Related Concept Videos

Cofactors and Coenzymes01:27

Cofactors and Coenzymes

Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
87.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
922
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
391
Introduction to Membrane Proteins01:16

Introduction to Membrane Proteins

The cell membrane, or plasma membrane, is an ever-changing landscape. It is described as a fluid mosaic where various macromolecules are embedded in the phospholipid bilayer. Among the macromolecules are proteins. The protein content varies across cell types. For example, mitochondrial inner membranes contain ~76% protein content, while myelin contains ~18% protein content. Individual cells contain many types of membrane proteins—red blood cells contain over 50—and different cell...
80.8K
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.2K